MicroRNA-15b contributes to ginsenoside-Rg1-induced angiogenesis through increased expression of VEGFR-2

Biochemical Pharmacology

Volumn 86, Issue 3, 2013, Pages 392-400

  Chan, L S ^a   Yue, Patrick Y K ^a   Wong, Y Y ^a   Wong, Ricky N S ^a  

^a HONG KONG BAPTIST UNIVERSITY   (Hong Kong)

Author keywords

Angiogenesis; Ginsenoside Rg1; HUVECs; Microrna 15b; VEGFR 2

Indexed keywords

GINSENOSIDE RG 1; LUCIFERASE; MICRORNA 15B; RNA PRECURSOR; VASCULOTROPIN RECEPTOR 2; ANGIOGENIC FACTOR; GINSENOSIDE; MICRORNA; MIRN15 MICRORNA, HUMAN;

3' UNTRANSLATED REGION; ANGIOGENESIS; ARTICLE; CELL MIGRATION; CELL MOTILITY; CONTROLLED STUDY; EMBRYO; FIBROBLAST CULTURE; GENE OVEREXPRESSION; GENE TARGETING; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; NONHUMAN; PRIORITY JOURNAL; REDUCTION; REPORTER GENE; SKIN CELL; UMBILICAL VEIN ENDOTHELIAL CELL; WILD TYPE; ZEBRA FISH; ANIMAL; BIOSYNTHESIS; CELL CULTURE; CELL MOTION; DRUG EFFECT; GINSENOSIDE-RG(1); HUVECS; MICRORNA-15B; PHYSIOLOGY; UPREGULATION; VEGFR-2;

ANGIOGENESIS; GINSENOSIDE-RG(1); HUVECS; MICRORNA-15B; VEGFR-2;

ANGIOGENESIS INDUCING AGENTS; ANIMALS; CELL MOVEMENT; CELLS, CULTURED; GINSENOSIDES; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; MICRORNAS; UP-REGULATION; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-2; ZEBRAFISH;

EID: 84884574556     PISSN: 00062952     EISSN: 18732968     Source Type: Journal    
DOI: 10.1016/j.bcp.2013.05.006     Document Type: Article

References (50)

1. Liu CX, Xiao PG. Recent advances on ginseng research in China. J Ethnopharmacol 1992;36:27-38.
2. Yun TK. Brief introduction of Panax gingeng C.A. Meyer. J Korean Med Sci Suppl 2001;16:3-5.
3. Park JD, Rhee DK, Lee YH. Biological activities and chemistry of saponins from Panax ginseng C.A. Meyer. Phytochem Rev 2005;4:159-75. (Pubitemid 41752174)
4. Wang X, Sakuma T, Asafu-Adjaye E, Shiu GK. Determination of ginsenosides in plant extracts from Panax ginseng and Panax quinquefolius L. by LC/MS/MS. Anal Chem 1999;71:1579-84. (Pubitemid 29185968)
5. Kenarova B, Neychev H, Hadjiivanova C, Petkov VD. Immunomodulating activity of ginsenoside Rg1 from Panax ginseng. Jpn J Pharmacol 1990;54: 447-54.
6. Rudakewich M, Ba F, Benishin CG. Neuroprotective actions of ginsenosides Rb(1) and Rg(1). Planta Med 2001;67:533-7.
7. Liang HC, Chen CT, Chang Y, Huang YC, Chen SC, Sung HW. Loading of a novel angiogenic agent, ginsenoside Rg1 in an acellular biological tissue for tissue regeneration. Tissue Eng 2005;11:835-46. (Pubitemid 40960786)
8. Kwok HH, Ng WY, Yang MS, Mak NK, Wong RN, Yue PY. The ginsenoside protopanaxatriol protects endothelial cells from hydrogen peroxide-induced cell injury and cell death by modulating intracellular redox status. Free Radic Biol Med 2010;48:437-45.
9. Cheng Y, Shen LH, Zhang JT. Anti-amnestic and anti-aging effects of ginsenoside Rg1 and Rb1 and its mechanism of action. Acta Pharmacol Sin 2005;26: 143-9. (Pubitemid 40203956)
10. Wang XD, Gu TX, Shi EY, Lu CM, Wang C. Effect and mechanism of panaxoside Rg1 on neovascularization in myocardial infarction rats. Chin J Integr Med 2010;16:162-6.
11. Wei HJ, Yang HH, Chen CH, Lin WW, Chen SC, Lai PH, et al. Gelatin microspheres encapsulated with a nonpeptide angiogenic agent, ginsenoside Rg1, for intramyocardial injection in a rat model with infarcted myocardium. J Control Release 2007;120:27-34.
12. Yin H, Liu Z, Li F, Ni M, Wang B, Qiao Y, et al. Ginsenoside-Rg1 enhances angiogenesis and ameliorates ventricular remodeling in a rat model of myocardial infarction. J Mol Med 2011;89:363-75.
13. Fan TP, Yeh JC, Leung KW, Yue PY, Wong RN. Angiogenesis: from plants to blood vessels. Trends Pharmacol Sci 2006;27:297-309. (Pubitemid 43850005)
14. Yue PY, Mak NK, Cheng YK, Leung KW, Ng TB, Fan DT, et al. Pharmacogenomics and the Yin/Yang actions of ginseng: anti-tumor, angiomodulating and steroid-like activities of ginsenosides. Chin Med 2007;15:1-26.
15. Folkman J, Shing Y. Angiogenesis. J Biol Chem 1992;267:10931-34.
16. Risau W. Mechanism of angiogenesis. Nature 1997;386:671-4.
17. Marchio S, Primo L, Pagano M, Palestro G, Albini A, Veikkola T, et al. VEGFs, receptors and angiogenesis. Semin Cancer Biol 1999;9:211-20. (Pubitemid 29273837)
18. Yue PY, Wong DY, Ha WY, Fung MC, Mak NK, Yeung HW, et al. Elucidation of the mechanisms underlying the angiogenic effects of ginsenoside Rg(1) in vivo and in vitro. Angiogenesis 2005;8:205-16. (Pubitemid 41759145)
19. Yue PYK, Cheng YK, Mak NK, Leung KW, Leung AST, Fan TP, et al. Ginseng and angiogenesis. In Angiogenesis: basic science and clinical application. 2007;p. 351-66 [chapter 21].
20. Lin KM, Hsu CH, Rajasekaran S. Angiogenic evaluation of ginsenoside Rg1 from Panax ginseng in fluorescent transgenic mice. Vascul Pharmacol 2008;49: 37-43.
21. Leung KW, Cheng YK, Mak NK, Chan KK, Fan TP, Wong RN. Signaling pathway of ginsenoside-Rg1 leading to nitric oxide production in endothelial cells. FEBS Lett 2006;580:3211-6. (Pubitemid 43729672)
22. Leung KW, Pon YL, Wong RN, Wong AS. Ginsenoside-Rg1 induces vascular endothelial growth factor expression through the glucocorticoid receptor-related phosphatidylinositol 3-kinase/Akt and beta-catenin/T-cell factor-dependent pathway in human endothelial cells. J Biol Chem 2006;281: 36280-88. (Pubitemid 46041363)
23. Leung KW, Ng HM, Tang MK, Wong CC, Wong RN, Wong AS. Ginsenoside-Rg1 mediates a hypoxia-independent upregulation of hypoxia-inducible factor-1a to promote angiogenesis. Angiogenesis 2011;14:515-22.
24. Bartel DP. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 2004;116:281-97.
25. Kim VN, Nam JW. Genomics of microRNA. Trends Genet 2006;22:165-73. (Pubitemid 43290020)
26. Ambros V. The functions of animal microRNAs. Nature 2004;431:350-5. (Pubitemid 39265675)
27. Erson AE, Petty EM. MicroRNAs in development and disease. Clin Genet 2008;74:296-306.
28. Urbich C, Kuehbacher A, Dimmeler S. Role of microRNAs in vascular diseases, inflammation, and angiogenesis. Cardiovasc Res 2008;79:581-8.
29. Zhang C. MicroRNAs in vascular biology and vascular disease. J Cardiovasc Transl Res 2010;3:235-40.
30. Chan LS, Yue PY, Mak NK, Wong RN. Role of microRNA-214 in ginsenoside-Rg1-induced angiogenesis. Eur J Pharm Sci 2009;38:370-7.
31. Kanno S, Oda N, Abe M, Terai Y, Ito M, Shitara K, et al. Roles of two VEGF receptors, Flt-1 and KDR, in the signal transduction of VEGF effects in human vascular endothelial cells. Oncogene 2000;19:2138-46. (Pubitemid 30251379)
32. Ferrara N, Gerber HP, LeCouter J. The biology of VEGF and its receptors. Nat Med 2003;9:669-76. (Pubitemid 36749215)
33. Yue PY, Leung EP, Mak NK, Wong RN. A simplified method for quantifying cell migration/wound healing in 96-well plates. J Biomol Screen 2010;15:427-33.
34. Chan YK, Kwok HH, Chan LS, Leung KS, Shi J, Mak NK, et al. An indirubin derivative, E804, exhibits potent angiosuppressive activity. Biochem Pharmacol 2012;83:598-607.
35. Kuehbacher A, Urbich C, Zeiher AM, Dimmeler S. Role of dicer and drosha for endothelial microRNA expression and angiogenesis. Circ Res 2007;101: 59-68. (Pubitemid 47094624)
36. Liu Z, Yang D, Xie P, Ren G, Sun G, Zeng X, et al. MiR-106b and MiR-15b modulate apoptosis and angiogenesis in myocardial infarction. Cell Physiol Biochem 2012;29:851-62.
37. Brennecke J, Stark A, Russell RB, Cohen SM. Principles of microRNA-target recognition. PLoS Biol 2005;3:404-18.
38. Doench JG, Sharp PA. Specificity of microRNA target selection in translational repression. Genes Dev 2004;18:504-11. (Pubitemid 38372808)
39. Holmes K, Roberts OL, Thomas AM, Cross MJ. Vascular endothelial growth factor receptor-2: structure, function, intracellular signalling and therapeutic inhibition. Cell Signal 2007;19:2003-12. (Pubitemid 47354167)
40. Fasanaro P, D'Alessandra Y, Di Stefano V, Melchionna R, Romani S, Pompilio G, et al. MicroRNA-210 modulates endothelial cell response to hypoxia and inhibits the receptor tyrosine kinase ligand Ephrin-A3. J Biol Chem 2008;283: 15878-83.
41. Wurdinger T, Tannous BA, Saydam O, Skog J, Grau S, Soutschek J, et al. miR-296 regulates growth factor receptor overexpression in angiogenic endothelial cells. Cancer Cell 2008;14:382-93.
42. Fish JE, Srivastava D. MicroRNAs: opening a new vein in angiogenesis research. Sci Signal 2009;2:1-7.
43. Sato Y, Kanno S, Oda N, Abe M, Ito M, Shitara K, et al. Properties of two VEGF receptors, Flt-1 and KDR, in signal transduction. Ann NY Acad Sci 2000;902: 201-7. (Pubitemid 30389124)
44. Sato Y, Abe M, Tanaka K, Iwasaka C, Oda N, Kanno S, et al. Signal transduction and transcriptional regulation of angiogenesis. Adv Exp Med Biol 2000;476: 109-15. (Pubitemid 32176130)
45. Wang DJ, Li QY, Xu SJ, Zeng N. Effect of ginsenoside Rg1 on angiogenesis after neonatal hypoxia ischemia brain damage in rats. Sichuan Da Xue Xue Bao Yi Xue Ban 2011;42:503-7.
46. Tang B, Qu Y, Wang D, Mu D. Targeting hypoxia inducible factor-1a: a novel mechanism of ginsenoside Rg1 for brain repair after hypoxia/ischemia brain damage. CNS Neurol Disord Drug Targets 2011;10:235-8.
47. Pan ZW, Lu YJ, Yang BF. MicroRNAs: a novel class of potential therapeutic targets for cardiovascular diseases. Acta Pharmacol Sin 2010;31:1-9.
48. Cross MJ, Claesson-Welsh L. FGF and VEGF function in angiogenesis: signalling pathways, biological responses and therapeutic inhibition. Trends Pharmacol Sci 2001;22:201-7. (Pubitemid 32244307)
49. Daubman S. MicroRNAs in angiogenesis and vascular smooth muscle cell function. Circ Res 2010;106:423-5.
50. Wang S, Olson EN. AngiomiRs-key regulators of angiogenesis. Curr Opin Genet Dev 2009;19:205-11.